Pathogenic Role of Epstein–Barr Virus in Lung Cancers
Human oncogenic viruses account for at least 12% of total cancer cases worldwide. Epstein–Barr virus (EBV) is the first identified human oncogenic virus and it alone causes ~200,000 cancer cases and ~1.8% of total cancer-related death annually. Over the past 40 years, increasing lines of evidence ha...
Main Authors: | David Becnel, Ramsy Abdelghani, Asuka Nanbo, Janardhan Avilala, Jacob Kahn, Li Li, Zhen Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/5/877 |
Similar Items
-
Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer
by: Fayez Kheir, et al.
Published: (2019-05-01) -
Lung Cancer in Patients who Presented with Lung Nodules or Lung Masses at Chest Clinic, Phrae Hospital 2013-2016
by: Parichat Niyomthong
Published: (2017-09-01) -
Extracellular Vesicles in Epstein-Barr Virus’ Life Cycle and Pathogenesis
by: Mengmeng Zhao, et al.
Published: (2019-02-01) -
Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment
by: Zaric Bojan, et al.
Published: (2011-02-01) -
Lung Cancer in Patients who Presented with Lung Nodules or Lung Masses at Chest Clinic, Phrae Hospital 2013-2016
by: Parichat Niyomthong, M.D.
Published: (2017-09-01)